Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing

Overview

Journal Adv Wound Care (New Rochelle)

Date 2014 Feb 15

PMID 24527344

Citations 202

Authors

Mohammadreza Pakyari

Ali Farrokhi

Mohsen Khosravi Maharlooei

Aziz Ghahary

Affiliations

Soon will be listed here.

Abstract

Significance: This review highlights the critical role of transforming growth factor beta (TGF-β)1-3 within different phases of wound healing, in particular, late-stage wound healing. It is also very important to identify the TGF-β1-controlling factors involved in slowing down the healing process upon wound epithelialization.

Recent Advances: TGF-β1, as a growth factor, is a known proponent of dermal fibrosis. Several strategies to modulate or regulate TGF's actions have been thoroughly investigated in an effort to create successful therapies. This study reviews current discourse regarding the many roles of TGF-β1 in wound healing by modulating infiltrated immune cells and the extracellular matrix.

Critical Issues: It is well established that TGF-β1 functions as a wound-healing promoting factor, and thereby if in excess it may lead to overhealing outcomes, such as hypertrophic scarring and keloid. Thus, the regulation of TGF-β1 in the later stages of the healing process remains as critical issue of which to better understand.

Future Directions: One hypothesis is that cell communication is the key to regulate later stages of wound healing. To elucidate the role of keratinocyte/fibroblast cross talk in controlling the later stages of wound healing we need to: (1) identify those keratinocyte-released factors which would function as wound-healing stop signals, (2) evaluate the functionality of these factors in controlling the outcome of the healing process, and (3) formulate topical vehicles for these antifibrogenic factors to improve or even prevent the development of hypertrophic scarring and keloids as a result of deep trauma, burn injuries, and any type of surgical incision.

Citing Articles

Multifunctional hydrogel targeting senescence to accelerate diabetic wound healing through promoting angiogenesis.

Yang H, Chen Y, Rong Y, Zhou Y, Li S, Li X J Nanobiotechnology. 2025; 23(1):177.

PMID: 40050885 PMC: 11884173. DOI: 10.1186/s12951-025-03274-5.

Suture-Mediated Delivery System Reduces the Incidence of Uterine Scarring Through the TGF-β Pathway.

Bai H, Zhang W, Yan X, Qiu L, Cui P, Chen W J Funct Biomater. 2025; 16(2).

PMID: 39997586 PMC: 11856170. DOI: 10.3390/jfb16020052.

Mitochondrial and tRNA Gene Variants Associated with Risk and Prognosis of Idiopathic Pulmonary Fibrosis.

Lee L, Jan I, Chou W, Liu W, Kuo Y, Chang C Int J Mol Sci. 2025; 26(3).

PMID: 39941146 PMC: 11818280. DOI: 10.3390/ijms26031378.

A high-resolution view of the immune and stromal cell response to infection in human volunteers.

Brothwell J, Wei Y, Wang J, Guo T, Zhang C, Fortney K mBio. 2025; 16(3):e0388524.

PMID: 39882906 PMC: 11898715. DOI: 10.1128/mbio.03885-24.

Strontium nitrate-dopped zinc oxide-loaded alginate gels with gentamicin for improved wound healing.

Hikmat S, Tarawneh O, Hamadneh L, Hamed R, Alhusban A, Hailat M J Mater Sci Mater Med. 2025; 36(1):2.

PMID: 39777561 PMC: 11706890. DOI: 10.1007/s10856-024-06836-5.

References

Waddington S, Crossley R, Sheard V, Howe S, Buckley S, Coughlan L . Gene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous wounding. Mol Ther. 2010; 18(12):2104-11. PMC: 2997585. DOI: 10.1038/mt.2010.174. View

Shirakata Y, Kimura R, Nanba D, Iwamoto R, Tokumaru S, Morimoto C . Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci. 2005; 118(Pt 11):2363-70. DOI: 10.1242/jcs.02346. View

Thompson H, Mih J, Krasieva T, Tromberg B, George S . Epithelial-derived TGF-beta2 modulates basal and wound-healing subepithelial matrix homeostasis. Am J Physiol Lung Cell Mol Physiol. 2006; 291(6):L1277-85. DOI: 10.1152/ajplung.00057.2006. View

KATZ A, Taichman L . A partial catalog of proteins secreted by epidermal keratinocytes in culture. J Invest Dermatol. 1999; 112(5):818-21. DOI: 10.1046/j.1523-1747.1999.00572.x. View

Kilani R, Guilbert L, Lin X, Ghahary A . Keratinocyte conditioned medium abrogates the modulatory effects of IGF-1 and TGF-beta1 on collagenase expression in dermal fibroblasts. Wound Repair Regen. 2007; 15(2):236-44. DOI: 10.1111/j.1524-475X.2007.00210.x. View

Tredget E, Demare J, Chandran G, Tredget E, Yang L, Ghahary A . Transforming growth factor-beta and its effect on reepithelialization of partial-thickness ear wounds in transgenic mice. Wound Repair Regen. 2005; 13(1):61-7. DOI: 10.1111/j.1067-1927.2005.130108.x. View

Ghahary A, Shen Y, Nedelec B, Scott P, Tredget E . Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem. 1995; 148(1):25-32. DOI: 10.1007/BF00929499. View

Bizet A, Liu K, Tran-Khanh N, Saksena A, Vorstenbosch J, Finnson K . The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors. Biochim Biophys Acta. 2011; 1813(5):742-53. DOI: 10.1016/j.bbamcr.2011.01.028. View

Richardson M . Acute wounds: an overview of the physiological healing process. Nurs Times. 2004; 100(4):50-3. View

10.

Munger J, Huang X, Kawakatsu H, Griffiths M, Dalton S, Wu J . The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999; 96(3):319-28. DOI: 10.1016/s0092-8674(00)80545-0. View

11.

Mead A, Wong T, Cordeiro M, Anderson I, Khaw P . Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci. 2003; 44(8):3394-401. DOI: 10.1167/iovs.02-0978. View

12.

Rennekampff H, Hansbrough J, Kiessig V, Dore C, Sticherling M, Schroder J . Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res. 2000; 93(1):41-54. DOI: 10.1006/jsre.2000.5892. View

13.

Bird J, Tyler J . Dexamethasone potentiates the stimulatory effect of insulin-like growth factor-I on collagen production in cultured human fibroblasts. J Endocrinol. 1994; 142(3):571-9. DOI: 10.1677/joe.0.1420571. View

14.

Fu H, Subramanian R, Masters S . 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol. 2000; 40:617-47. DOI: 10.1146/annurev.pharmtox.40.1.617. View

15.

Ghahary A, Marcoux Y, Karimi-Busheri F, Li Y, Tredget E, Kilani R . Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol. 2005; 124(1):170-7. DOI: 10.1111/j.0022-202X.2004.23521.x. View

16.

Hosokawa R, Nonaka K, Morifuji M, Shum L, Ohishi M . TGF-beta 3 decreases type I collagen and scarring after labioplasty. J Dent Res. 2003; 82(7):558-64. DOI: 10.1177/154405910308200714. View

17.

Shi Y, Massague J . Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003; 113(6):685-700. DOI: 10.1016/s0092-8674(03)00432-x. View

18.

Ashcroft G, Yang X, Glick A, Weinstein M, Letterio J, Mizel D . Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol. 1999; 1(5):260-6. DOI: 10.1038/12971. View

19.

Schrementi M, Ferreira A, Zender C, DiPietro L . Site-specific production of TGF-beta in oral mucosal and cutaneous wounds. Wound Repair Regen. 2007; 16(1):80-6. DOI: 10.1111/j.1524-475X.2007.00320.x. View

20.

Border W, Noble N . Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994; 331(19):1286-92. DOI: 10.1056/NEJM199411103311907. View